nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Abacavir—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Abacavir—Malaise—Prednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Abacavir—Vertigo—Prednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Abacavir—Convulsion—Prednisolone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Abacavir—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Abacavir—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Abacavir—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Abacavir—Alopecia—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Abacavir—Alopecia—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Abacavir—Discomfort—Prednisolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Abacavir—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Abacavir—Malaise—Triamcinolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Abacavir—Malaise—Methylprednisolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Abacavir—Vertigo—Triamcinolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Abacavir—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Abacavir—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Abacavir—Oedema—Prednisolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Abacavir—Neutropenia—Methotrexate—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Abacavir—Cough—Triamcinolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Abacavir—Convulsion—Triamcinolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Abacavir—Convulsion—Methylprednisolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Abacavir—Myalgia—Triamcinolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Abacavir—Pneumonia—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Abacavir—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Abacavir—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Abacavir—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Abacavir—Depression—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Abacavir—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Abacavir—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Abacavir—Discomfort—Triamcinolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Abacavir—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Abacavir—Renal failure—Methotrexate—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Abacavir—Stomatitis—Methotrexate—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Abacavir—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Abacavir—Immune system disorder—Prednisone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Abacavir—Malaise—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Abacavir—Malaise—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Abacavir—Oedema—Triamcinolone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Abacavir—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Abacavir—Vertigo—Dexamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Abacavir—Vertigo—Betamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Abacavir—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Abacavir—Infection—Triamcinolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Abacavir—Infection—Methylprednisolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Abacavir—Insomnia—Prednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Abacavir—Alopecia—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Abacavir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Abacavir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Abacavir—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Abacavir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Abacavir—Malnutrition—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Abacavir—Convulsion—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Abacavir—Convulsion—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Abacavir—Myalgia—Betamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Abacavir—Myalgia—Dexamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Abacavir—Anxiety—Dexamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Abacavir—Anxiety—Betamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Abacavir—Discomfort—Dexamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Abacavir—Discomfort—Betamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Abacavir—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Abacavir—Pain—Prednisolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Abacavir—Hepatitis—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Abacavir—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Abacavir—Oedema—Betamethasone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Abacavir—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Abacavir—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Abacavir—Oedema—Dexamethasone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Abacavir—Insomnia—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Abacavir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Abacavir—Infection—Dexamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Abacavir—Infection—Betamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Abacavir—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Abacavir—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Abacavir—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Abacavir—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Abacavir—Anaemia—Prednisone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Abacavir—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Abacavir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Abacavir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Abacavir—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Abacavir—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Abacavir—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Abacavir—Malaise—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Abacavir—Vertigo—Prednisone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Abacavir—Anorexia—Betamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Abacavir—Anorexia—Dexamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Abacavir—Urticaria—Prednisolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Abacavir—Fatigue—Triamcinolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Abacavir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Abacavir—Pain—Triamcinolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Abacavir—Hypotension—Betamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Abacavir—Hypotension—Dexamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Abacavir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Abacavir—Convulsion—Prednisone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Abacavir—Chills—Methotrexate—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Abacavir—Myalgia—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Abacavir—Arthralgia—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Abacavir—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Abacavir—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Abacavir—Anxiety—Prednisone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Abacavir—Alopecia—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Abacavir—Insomnia—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Abacavir—Insomnia—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Abacavir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Abacavir—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Abacavir—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Abacavir—Discomfort—Prednisone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Abacavir—Malnutrition—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Abacavir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Abacavir—Urticaria—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Abacavir—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Abacavir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Abacavir—Oedema—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Abacavir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Abacavir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Abacavir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Abacavir—Infection—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Abacavir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Abacavir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Abacavir—Fatigue—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Abacavir—Fatigue—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Abacavir—Pain—Dexamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Abacavir—Pain—Betamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Abacavir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Abacavir—Skin disorder—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Abacavir—Anorexia—Prednisone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Abacavir—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Abacavir—Anaemia—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Abacavir—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Abacavir—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Abacavir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Abacavir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Abacavir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Abacavir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Abacavir—Malaise—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Abacavir—Vertigo—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Abacavir—Leukopenia—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Abacavir—Urticaria—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Abacavir—Urticaria—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Abacavir—Dizziness—Prednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Abacavir—Asthenia—Triamcinolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Abacavir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Abacavir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Abacavir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Abacavir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Abacavir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Abacavir—Insomnia—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Abacavir—Paraesthesia—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Abacavir—Pruritus—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Abacavir—Cough—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Abacavir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Abacavir—Convulsion—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Abacavir—Myalgia—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Abacavir—Decreased appetite—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Abacavir—Rash—Prednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Abacavir—Dermatitis—Prednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Abacavir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Abacavir—Fatigue—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Abacavir—Headache—Prednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Abacavir—Discomfort—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Abacavir—Dizziness—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Abacavir—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Abacavir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Abacavir—Infection—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Abacavir—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Abacavir—Asthenia—Dexamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Abacavir—Asthenia—Betamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Abacavir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Abacavir—Nausea—Prednisolone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Abacavir—Pruritus—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Abacavir—Pruritus—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Abacavir—Vomiting—Triamcinolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Abacavir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Abacavir—Rash—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Abacavir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Abacavir—Anorexia—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Abacavir—Rash—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Abacavir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Abacavir—Urticaria—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Abacavir—Headache—Triamcinolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Abacavir—Headache—Methylprednisolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Abacavir—Body temperature increased—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Abacavir—Abdominal pain—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Abacavir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Abacavir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Abacavir—Hypotension—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Abacavir—Dizziness—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Abacavir—Dizziness—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Abacavir—Insomnia—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Abacavir—Nausea—Triamcinolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Abacavir—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Abacavir—Nausea—Methylprednisolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Abacavir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Abacavir—Vomiting—Betamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Abacavir—Vomiting—Dexamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Abacavir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Abacavir—Rash—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Abacavir—Rash—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Abacavir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Abacavir—Dermatitis—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Abacavir—Fatigue—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Abacavir—Headache—Dexamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Abacavir—Headache—Betamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Abacavir—Asthenia—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Abacavir—Pain—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Abacavir—Pruritus—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Abacavir—Diarrhoea—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Abacavir—Nausea—Dexamethasone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Abacavir—Nausea—Betamethasone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Abacavir—Urticaria—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Abacavir—Dizziness—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Abacavir—Vomiting—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Abacavir—Rash—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Abacavir—Dermatitis—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Abacavir—Headache—Prednisone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Abacavir—Asthenia—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Abacavir—Nausea—Prednisone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Abacavir—Pruritus—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Abacavir—Dizziness—Methotrexate—ankylosing spondylitis	0.000991	0.000991	CcSEcCtD
Abacavir—Vomiting—Methotrexate—ankylosing spondylitis	0.000953	0.000953	CcSEcCtD
Abacavir—Rash—Methotrexate—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—ankylosing spondylitis	0.000944	0.000944	CcSEcCtD
Abacavir—Headache—Methotrexate—ankylosing spondylitis	0.000939	0.000939	CcSEcCtD
Abacavir—Nausea—Methotrexate—ankylosing spondylitis	0.00089	0.00089	CcSEcCtD
